5'-CARBAMOYL-1,1'-BIPHENYL-4-CA RBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS

Details for Australian Patent Application No. 2002346927 (hide)

Owner GLAXO GROUP LIMITED

Inventors COCKERILL, George, Stuart; MERRICK, Suzanne, Joy; WALKER, Ann, Louise; ANGELL, Richard, Martyn; ASTON, Nicola, Mary; BAMBOROUGH, Paul; BAMFORD, Mark, James

Pub. Number AU-A-2002346927

PCT Number PCT/EP02/11573

PCT Pub. Number WO2003/032980

Priority 0124931.7 17.10.01 GB

Filing date 16 October 2002

Wipo publication date 28 April 2003

International Classifications

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/4453 - only substituted in position 1, e.g. propipocaine, diperodon

A61K 031/4465 - only substituted in position 4

A61K 031/426 - 1,3-Thiazoles

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

C07D 211/26 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 277/28 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/18 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/14 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/52 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 233/61 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/417

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 0124931.7 17.10.01 GB

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002346927

1 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346928-2'-METHYL-5'-(1,3,4-OXADIAZOL-2-YL )-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS

2002346926-BIPHENYLCARBOXYLIC AMIDE DERIVATIVES AS P38 KINASE INHIBITORS